Absence of progression of recurrent bleomycin skin toxicity without postponement or attenuation of therapy.
Bennett
J P
JP
University of Iowa College of Medicine, Iowa City 52242.
Burns
C P
CP
D001761:Bleomycin / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013601:T-Lymphocytes
D001761:Bleomycin